tradingkey.logo

ICU Medical Inc

ICUI
查看詳細走勢圖
142.670USD
-1.960-1.36%
收盤 12/31, 16:00美東報價延遲15分鐘
3.52B總市值
虧損本益比TTM

ICU Medical Inc

142.670
-1.960-1.36%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.36%

5天

-2.93%

1月

-3.89%

6月

+7.96%

今年開始到現在

0.00%

1年

-8.06%

查看詳細走勢圖

TradingKey ICU Medical Inc股票評分

單位: USD 更新時間: 2025-12-31

操作建議

ICU Medical Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名45/206位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價181.40。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

ICU Medical Inc評分

相關信息

行業排名
45 / 206
全市場排名
132 / 4560
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 6 分析師
買入
評級
181.400
目標均價
+26.17%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

ICU Medical Inc亮點

亮點風險
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入2.38B美元
估值低估
公司最新PE估值-471.17,處於3年歷史低位
機構加倉
最新機構持股27.90M股,環比增加4.32%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉97.00股
活躍度增加
近期活躍度增加,過去20天平均換手率0.36

ICU Medical Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

ICU Medical Inc簡介

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
公司代碼ICUI
公司ICU Medical Inc
CEOJain (Vivek)
網址https://www.icumed.com/

常見問題

ICU Medical Inc(ICUI)的當前股價是多少?

ICU Medical Inc(ICUI)的當前股價是 142.670。

ICU Medical Inc 的股票代碼是什麼?

ICU Medical Inc的股票代碼是ICUI。

ICU Medical Inc股票的52週最高點是多少?

ICU Medical Inc股票的52週最高點是175.510。

ICU Medical Inc股票的52週最低點是多少?

ICU Medical Inc股票的52週最低點是107.000。

ICU Medical Inc的市值是多少?

ICU Medical Inc的市值是3.52B。

ICU Medical Inc的淨利潤是多少?

ICU Medical Inc的淨利潤為-117.69M。

現在ICU Medical Inc(ICUI)的股票是買入、持有還是賣出?

根據分析師評級,ICU Medical Inc(ICUI)的總體評級為買入,目標價格為181.400。

ICU Medical Inc(ICUI)股票的每股收益(EPS TTM)是多少

ICU Medical Inc(ICUI)股票的每股收益(EPS TTM)是-0.303。
KeyAI